Suvretta Capital Management’s ProKidney PROK Stock Holding History

Suvretta Capital Management’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.1M	Hold	12,341,266	–	–	0.56%	44
2025 Q4	$27.6M	Hold	12,341,266	–	–	0.57%	49
2025 Q3	$29.9M	Hold	12,341,266	–	–	0.76%	43
2025 Q2	$7.31M	Hold	12,341,266	–	–	0.22%	57
2025 Q1	$10.8M	Hold	12,341,266	–	–	0.4%	54
2024 Q4	$20.9M	Hold	12,341,266	–	–	0.71%	43
2024 Q3	$23.7M	Buy	12,341,266 +3,000,000	+32%	+$6.81M	0.76%	42
2024 Q2	$23M	Buy	9,341,266 +5,473,419	+142%	+$14.7M	0.84%	38
2024 Q1	$6.34M	Hold	3,867,847	–	–	0.24%	61
2023 Q4	$6.88M	Buy	3,867,847 +4	+0%	+$9	0.31%	49
2023 Q3	$17.7M	Buy	3,867,843 +674,668	+21%	+$6.46M	0.96%	33
2023 Q2	$35.7M	Hold	3,193,175	–	–	1.91%	17
2023 Q1	$36.1M	Hold	3,193,175	–	–	1.53%	26
2022 Q4	$21.9M	Hold	3,193,175	–	–	0.92%	37
2022 Q3	$28.8M	Buy	+3,193,175	New	+$27.8M	1.19%	31

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Suvretta Capital Management's PROK Position: Q1 2026 in Review

Suvretta Capital Management held its ProKidney (PROK) position steady in Q1 2026 at 12,341,266 shares worth $22.1M. The position accounts for 0.56% of the portfolio, ranked #44.

Suvretta Capital Management first reported a position in PROK in Q3 2022 and has held it in 15 quarters since. The position peaked at $36.1M in Q1 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

Suvretta Capital Management held 12,341,266 shares of ProKidney worth $22.1M as of Q1 2026.
Suvretta Capital Management left its ProKidney share count unchanged in Q1 2026.
ProKidney made up 0.56% of Suvretta Capital Management's portfolio in Q1 2026, its #44 holding.
Suvretta Capital Management first reported a position in ProKidney in Q3 2022 and has held it in 15 quarters since.
Suvretta Capital Management's ProKidney position peaked at $36.1M in Q1 2023.
71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.